Systemic Treatments for Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Old Certainties and New Frontiers

Epidermal growth factor receptor 2 (EGFR2, also known as HER2) overexpression and/or amplification confers a more aggressive clinical behavior but also represents a therapeutic opportunity for targeted therapies in breast cancer (BC). Over the last 2 decades, the prognosis of HER2-positive metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessandro, Cusmai, Antonio, Massafra, Raffaella, Bove, Samantha, Comes, Maria Colomba, Fanizzi, Annarita, Gadaleta-Caldarola, Gennaro, Oreste, Donato, Zito, Alfredo, Giotta, Francesco, Lorusso, Vito, Palmiotti, Gennaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160897/
http://dx.doi.org/10.1177/10732748221106267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160897/
http://dx.doi.org/10.1177/10732748221106267

Ejemplares similares